96715 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
Sub-classes:AMINO ACID-MODIFIED LIPIDS FOR RNA DELIVERY
#2PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS
#3PEPTIDE HAVING ACE INHIBITORY ACTIVITY AND COMPOSITION CONTAINING THE SAME
#4TREATMENTS FOR DISEASES AND DISORDERS THAT INVOLVE OXIDATIVE STRESS
#5FAP-ACTIVATED PROTEASOME INHIBITORS FOR TREATING SOLID TUMORS
#6Azole Tripeptides as Vasodilators
#7Protease inhibitors
#8TRANSFECTION COMPLEXES AND METHODS OF USING THE SAME
#9MODULATORS OF SORTILIN ACTIVITY
#10PROTEASE INHIBITORS FOR TREATING OR PREVENTING CORONAVIRUS INFECTION
#11TREATMENTS FOR DISEASES AND DISORDERS THAT INVOLVE OXIDATIVE STRESS
#12Process for the preparation of cyclic depsipeptides
#13PEPTIDE HAVING PROTECTIVE ACTIVITY AGAINST CELL DAMAGE CAUSED BY PARTICULATE MATTER, AND USES FOR SAME
#14PEPTIDE TAG AND TAGGED PROTEIN CONTAINING SAME
#15MPRO CYSTEINE PROTEASE INHIBITORS
#16COMPOUNDS HAVING TRIPLE ACTIVITIES OF THROMBOLYSIS, ANTITHROMBOTIC AND RADICAL SCAVENGING
#17USE OF PEPTIDES AS THERAPEUTIC AGENT FOR AUTOIMMUNE DISEASES AND BONE DISEASES
#18MODIFIED PEPTIDE NUCLEIC ACID COMPOSITIONS
#19COLLAGEN MIMICS
#20MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#21MELANOMA THERAPEUTICS
#22Peptide macrocycles against
#23Modified peptide nucleic acid compositions
#24PEPTIDE ACETALS FOR STABILISING ENZYMES
#25Piezoelectric peptide-based materials and piezoelectric devices containing same
#26INHIBITORS OF GROWTH FACTOR ACTIVATION ENZYMES
#27MODIFIED PEPTIDE NUCLEIC ACID COMPOSITIONS
#28Transfection complexes and methods of using the same
#29PEPTIDE INHIBITORS OF TIGHT JUNCTION PERMEABILITY
#30Process for the preparation of cyclic depsipeptides
#31Humidity-responsive tripeptide crystal
#32FAP-activated proteasome inhibitors for treating solid tumors
#33COMPOUNDS HAVING TRIPLE ACTIVITIES OF THROMBOLYSIS, ANTITHROMBOTIC AND RADICAL SCAVENGING
#34LLP2A-BISPHOSPHONATE CONJUGATES FOR OSTEOPOROSIS TREATMENT
#35PROCESS FOR THE LIQUID PHASE SYNTHESIS OF H-INP-(D)BAL-(D)TRP-PHE-APC-NH2, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
#36MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#37Inhibitors of blood coagulation factor XIII
#38Modified peptides for use in treating neurodegenerative disorders
#39Compositions comprising cyclic peptides derived from an A-beta peptide
#40PEPTIDE COMPOSITIONS AND RELATED METHODS
#41LLP2A-BISPHOSPHONATE CONJUGATES FOR OSTEOPOROSIS TREATMENT
#42PEPTIDE COMPOSITIONS AND RELATED METHODS
#43Process for the preparation of cyclic depsipeptides
#44FAP-activated proteasome inhibitors for treating solid tumors
#45Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
#46POSITIVE ALLOSTERIC MODULATORS OF GABA A RECEPTOR
#47Use of peptides as therapeutic agent for autoimmune diseases and bone diseases
#48Pro-pigmenting peptides
#49Peptide inhibitors of tight junction permeability
#50Tripeptide epoxy ketone protease inhibitors
#51PROCESS FOR THE LIQUID PHASE SYNTHESIS OF H-INP-(D)BAL-(D)TRP-PHE-APC-NH2, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
#52Small molecule DCN1 inhibitors and therapeutic methods using the same
#53Epoxyketone compounds for enzyme inhibition
#54COMPOUNDS HAVING TRIPLE ACTIVITIES OF THROMBOLYSIS, ANTITHROMBOTIC AND RADICAL SCAVENGING
#55Collagen mimics
#56MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#57MALT1 inhibitors and uses thereof
#58Inhibitors of transglutaminases
#59Peptide macrocycles against
#60Compounds
#61Process for the preparation of cyclic depsipeptides
#62Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#63Pro-pigmenting peptides
#64Neuropeptide S receptor (NPSR) agonists
#65Water-soluble peptide fluorescence material
#66METHODS OF TREATING DEPRESSION AND OTHER RELATED DISEASES
#67FAP-activated proteasome inhibitors for treating solid tumors
#68Trifluoromethylpropanamide derivatives as HTRA1 inhibitors
#69Peptide macrocycles against Acinetobacter baumannii
#70Transfection complexes and methods of using the same
#71NOVEL LIGANDS FOR PREVENTION OF NEUROTOXICITY OF THE ALZHEIMER'S DISEASE RELATED AMYLOID-BETA PEPTIDE
#72Medical Use
#73Compound with effects of thrombolysis, free radical scavenging and thrombus-targeting
#74MALT1 inhibitors and uses thereof
#75Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof
#76Selective cysteine protease inhibitors and uses thereof
#77Prodrugs of peptide epoxy ketone protease inhibitors
#78Inhibition of gliadin peptides
#79Process for preparing compounds having triple activities of thrombolysis, antithrombosis, and radical scavenging
#80NOVEL EPHA4 INHIBITORS TARGETING ITS LIGAND BINDING DOMAIN
#81Methods of treating depression and other related diseases
#82Method of using pharmaceutical compositions comprising selective peptide-based agonists of melanocortin 1 receptor
#83Inhibitors of growth factor activation enzymes
#84Indoline compounds as granzyme B inhibitors
#85Water-soluble peptide fluorescence material
#86Collagen mimics
#87Substrates and inhibitors of prolyl oligopeptidase and methods of use thereof
#88Compounds for enzyme inhibition
#89Peptide macrocycles against acinetobacter baumannii
#90Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
#91Use of a tetraphenylborate (TPB) salt for the separation of biomolecules
#92LLP2A-bisphosphonate conjugates for osteoporosis treatment
#93Epoxyketone compounds for enzyme inhibition
#94Agonists of neurotrophin receptors and their use as medicaments
#95Dipeptides as inhibitors of human immunoproteasomes
#96INHIBITION OF GLIADIN PEPTIDES
#97Pro-pigmenting peptides
#98Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof
#99Covalent granzyme B inhibitors
#100PYRROLIDINE CARBOXAMIDO DERIVATIVES AND METHODS FOR PREPARING AND USING THE SAME
#101Branched chain-containing aromatic compound
#102Tripeptide epoxy ketone protease inhibitors
#103FAP-activated proteasome inhibitors for treating solid tumors
#104Ligands for prevention of neurotoxicity of the alzheimer's disease related amyloid-beta peptide
#105Prodrugs of peptide epoxy ketone protease inhibitors
#106HCV protease inhibitors and uses thereof
#107Thieno[2,3-e]indole derivatives as new antitumor agents
#108Composition comprising peptide derived from adiponectin
#109Intermediates for macrocyclic compounds
#110METHODS OF MAKING CARFILZOMIB AND INTERMEDIATES THEREOF
#111Proprotein convertase subtilisin kexin type 9 (PCSK9) allosteric binding ligands to modulate serum low density lipoprotein (LDL) levels
#112Compounds having triple activities of thrombolysis, antithrombosis, and radical scavenging, synthesis, and use thereof
#113Indoline compounds as granzyme B inhibitors
#114Estrogen-related receptor alpha based protac compounds and associated methods of use
#115Dipeptide and tripeptide epoxy ketone protease inhibitors
#116Vectors for delivery of agents across biological membranes
#117Process for preparing tubulysins
#118Prodrugs of heteraromatic compounds
#119Methods of treating depression and other related diseases
#120Compounds for enzyme inhibition
#121Process for producing Sovaprevir
#122Skin care compositions and methods comprising selective agonists of melanocortin 1 receptor
#123Pharmaceutical compositions comprising selective peptide-based agonists of melanocortin 1 receptor
#124Pro-pigmenting peptides
#125INHIBITION OF GLIADIN PEPTIDES
#126HCV protease inhibitors and uses thereof
#127Crystalline tripeptide epoxy ketone protease inhibitors
#128Macrocyclic and peptidomimetic compounds as broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, caliciviruses and coronaviruses
#129Substrates and inhibitors of prolyl oligopeptidase and methods of use
#130Cyclin based inhibitors of CDK2 and CDK4
#131Macrocyclic compounds useful as inhibitors of histone deacetylases
#132Agonists of neurotrophin receptors and their use as medicaments
#133High purity lipopeptides
#134Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof
#135Method of treating endometriosis
#136HEMIASTERLIN DERIVATIVES AND USES THEREOF IN THE TREATMENT OF CANCER
#137HCV NS3 protease inhibitors
#138Processes for Producing sovaprevir
#139FAP-activated proteasome inhibitors for treating solid tumors
#140Histone deacetylase inhibitors and synthetic method thereof and use thereof in manufacture of medicaments
#141Treatments for
#142Prion protein ligands and methods of use
#143PEPTOID COMPOSITIONS AND METHODS OF USING THE SAME
#144Prodrugs of peptide epoxy ketone protease inhibitors
#145Prodrugs of peptide epoxy ketone protease inhibitors
#146Hydrogel-forming material
#147Compounds for enzyme inhibition
#148Compounds for enzyme inhibition
#149Selective cysteine protease inhibitors and uses thereof
#150Compounds for enzyme inhibition
#151Crystalline tripeptide epoxy ketone protease inhibitors
#152Neuroprotective and neurorestorative methods and compositions
#153HCV protease inhibitors and uses thereof
#154Methods of treating depression and other related diseases
#155Methods of treating depression and other related diseases
#156Methods of treating depression and other related diseases
#157High purity lipopeptides
#158Antiviral compounds
#159COMPOUNDS FOR ENZYME INHIBITION
#160Peptides that inhibit angiotensin converting enzyme and peptides with antioxidant activity purified from ovotransferrin and methods of producing and using the same
#161Peptides or Antibodies Which Bind to Melanoma Inhibitory Activity (MIA) Protein
#162Antiviral compounds
#163Compounds for enzyme inhibition
#164Compounds for enzyme inhibition
#165Compounds for enzyme inhibition
#166HCV protease inhibitors and uses thereof
#167Methods of treating depression and other related diseases
#168Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use
#169Hemiasterlin derivatives and uses thereof in the treatment of cancer
#170Methods of treating depression and other related diseases
#171PROCESSES FOR INTERMEDIATES FOR MACROCYCLIC COMPOUNDS
#172PROCESSES FOR INTERMEDIATES FOR MACROCYCLIC COMPOUNDS
#173PROCESSES FOR INTERMEDIATES FOR MACROCYCLIC COMPOUNDS
#174Antiviral compounds
#175HCV protease inhibitors and uses thereof
#176PROCESSES FOR INTERMEDIATES FOR MACROCYCLIC COMPOUNDS
#177INHIBITORS OF INTERLEUKIN-1 BETA CONVERTING ENZYME
#178High purity lipopeptides
#179Tripeptide boronic acid or boronic ester, preparative method and use thereof
#180Method of treating tumors
#181Crystalline tripeptide epoxy ketone protease inhibitors
#182Compounds for enzyme inhibition
#183Crystalline tripeptide epoxy ketone protease inhibitors
#184Branched chain-containing aromatic compound
#185Agonists of neurotrophin receptors and their use as medicaments
#186Neuroprotective and neurorestorative method and compositions
#187Prodrugs of heteraromatic compounds
#188G-TYPE PEPTIDES AND OTHER AGENTS TO AMELIORATE ATHEROSCLEROSIS AND OTHER PATHOLOGIES
#189ANTIOXIDANT AGENT
#190Inhibition of gliadin peptides
#191Compounds and compositions as channel activating protease inhibitors
#192Processes for intermediates for macrocyclic compounds
#193Spatially-defined macrocyclic compounds useful for drug discovery
#194IAP BINDING COMPOUNDS
#195High purity lipopeptides
#196Labeling dye for detecting biomolecule, labeling kit, and method for detecting biomolecule
#197PEPTIDE VACCINE FOR INFLUENZA VIRUS
#198Inhibitors of interleukin-1β converting enzyme
#199Use of a tetraphenylborate (TPB) salt for the separation of biomolecules
#200Peptide manufacturing process
#201Substituted pyrrolo[1,2-d][1,4]-diazonines and treatment of brain damage
#202PEPTIDE TURN MIMETICS
#203Branched water-soluble polymers and their conjugates
#204POLYPEPTIDE
#205Lipid tripeptide-based hydrogelator and hydrogel
#206Antimicrobial compounds and formulations
#207Nucleic acid binding compounds and methods of use
#208IAP BINDING COMPOUNDS
#209CRYSTALLINE TRIPEPTIDE EPOXY KETONE PROTEASE INHIBITORS
#210PEPTIDES AND PEPTIDE MIMETICS TO INHIBIT THE ONSET AND/OR PROGRESSION OF FIBROTIC AND/OR PRE-FIBROTIC PATHOLOGIES
#211Compounds and methods for modulating cadherin-mediated processes
#212Methods and intermediates for chemical synthesis of polypeptides and proteins
#213Targeted polymeric prodrugs containing multifunctional linkers
#214PEPTIDES AND PEPTIDE MIMETICS TO TREAT CANCER
#215SUBSTITUTED 1,2-ETHYLENEDIAMINES, METHODS FOR PREPARING THEM AND USES THEREOF
#216Antimicrobial peptides
#217Compounds for enzyme inhibition
#218Compounds for enzyme inhibition
#219Hepatitis C Virus Inhibitors
#220PEPTIDE VACCINE FOR INFLUENZA VIRUS
#221HCV protease inhibitors and uses thereof
#222Selective Caspase Inhibitors
#223Hemiasterlin derivatives and uses thereof in the treatment of cancer
#224HCV protease inhibitors and uses thereof
#225HCV protease inhibitors and uses thereof
#226METHOD FOR DEGRADING PEPTIDES, METHOD FOR ANALYZING PEPTIDES, DEVICE FOR DEGRADING PEPTIDES AND DEVICE FOR ANALYZING PEPTIDES
#227Substituted 1,2-ethylenediamines, Methods for Preparing Them and Uses Thereof
#228COMPOUNDS FOR THE INHIBITION OF APOPTOSIS
#229ENDOTHELIN RECEPTOR ANTAGONIST DERIVATIVES
#230Macrocyclic compounds as antiviral agents
#231Plasma protein-binding ligands
#232Antiviral compounds
#233Selective substrates for matrix metalloproteinases
#234Intermediates for macrocyclic compounds
#235SMALL PEPTIDIC AND PEPTIDO-MIMETIC AFFINITY LIGANDS FOR FACTOR VIII AND FACTOR VIII-LIKE PROTEINS
#236Compounds for enzyme inhibition
#237Antiviral compounds
#238Processes for intermediates for macrocyclic compounds
#239Spatially-defined macrocyclic compounds useful for drug discovery
#240Methods and compositions for increasing skin remodeling
#241Topical application agents against mimic and age-related wrinkles
#242POLYPEPTIDE
#243Antibacterial compounds
#244HCV NS3 protease inhibitors
#245Methods for the directed expansion of epitopes for use as antibody ligands
#246Composite material useful as biomaterial and its preparation
#247MACROCYCLIC ANTAGONISTS OF THE MOTILIN RECEPTOR FOR MODULATION OF THE MIGRATING MOTOR COMPLEX
#248Peptides that antagonize FPR class receptor mediated signaling
#249Prion protein ligands and methods of use
#250Cyclic P3 tripeptide hepatitis C serine protease inhibitors
#251Thyrotropin-Releasing Hormone Analogs and Method of Use
#252Therapeutic uses of tri-, tetra-, penta-, and polypeptides
#253Anti-hypertensive molecules and process for preparation thereof
#254Plasma protein-binding ligands
#255Methods for designing and synthesizing directed sequence polymer compositions via the directed expansion of epitope permeability
#256Hemiasterlin Derivatives and Uses Thereof
#257Hemiasterlin derivatives and uses thereof in the treatment of cancer
#258Inhibitors of interleukin-1β converting enzyme
#259Compounds for enzyme inhibition
#260Compounds and compositions as channel activating protease inhibitors
#261Collagen mimics
#262Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels
#263High purity lipopeptides
#264Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
#265Pyrrolidine melanocortin-specific compounds
#266PROCESS FOR PREPARING VAPREOTIDE
#267Compounds for enzyme inhibition
#268Base-substituted benzylamine analogs for use as coagulation factor Xa inhibitors, the production and use thereof
#269IAP binding compounds
#270Branched water-soluble polymers and their conjugates
#271Polypeptide
#272Beta-sheet mimetics and methods relating to the use thereof
#273TRH-degrading ectoenzyme inhibitors
#274β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
#275Substituted 1,2-ethylenediamines, methods for preparing them and uses thereof
#276Neuroprotective macrocyclic compounds and methods for their use
#277G-type peptides and other agents to ameliorate atherosclerosis and other pathologies
#278Anti-hypertensive molecules and process for preparation thereof
#2792-hydroxytetrahydrofuran derivatives and use thereof as medicaments
#280Hemiasterlin derivatives and uses thereof
#281Ultra-high specificity fluorescent labeling
#282Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (iap)
#283Melanocortin receptor ligands
#284Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (IAP)
#285Granzyme b inhibitors
#286Cyclic peptides for treatment for cachexia
#287Cyclic peptides for treatment of cachexia
#288Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm
#289Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
#290Agents and methods for promoting bone growth
#291Hemiasterlin derivatives and uses thereof
#292Piperidine compounds
#293Derivatives of 2-hydroxytetrahydrofuran and their use as medicaments
#294Di-, tri-, and tetra-peptides having antiangiogenic activity
#295Process of removing transition metals
#296Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
#297Selective substrates for matrix metalloproteinases
#298Inhibitors of interleukin-1beta converting enzyme
#299Conformationally-controlled biologically active macrocyclic small molecules as motilin antagonists or ghrelin agonists
#300Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels